|
PTGES3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.241600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.371200E-01 |
| Normal-vs-Stage2 |
7.345800E-01 |
| Normal-vs-Stage3 |
1.065550E-01 |
| Normal-vs-Stage4 |
3.369000E-01 |
| Stage1-vs-Stage2 |
9.085200E-01 |
| Stage1-vs-Stage3 |
2.173800E-01 |
| Stage1-vs-Stage4 |
6.414800E-01 |
| Stage2-vs-Stage3 |
3.914400E-01 |
| Stage2-vs-Stage4 |
7.212400E-01 |
| Stage3-vs-Stage4 |
5.131000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.356600E-01 |
| Normal-vs-AfricanAmerican |
3.721000E-03 |
| Normal-vs-Asian |
9.144000E-01 |
| Caucasian-vs-AfricanAmerican |
6.400700E-03 |
| Caucasian-vs-Asian |
8.447600E-01 |
| AfricanAmerican-vs-Asian |
1.854240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.066200E-01 |
| Normal-vs-Female |
3.934200E-01 |
| Male-vs-Female |
7.033400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.996500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.878600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.586200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.240400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.969600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.349700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.339000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.341200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.452600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.216400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.899200E-01 |
| Normal-vs-Grade 2 |
6.444400E-01 |
| Normal-vs-Grade 3 |
1.229760E-02 |
| Normal-vs-Grade 4 |
4.683900E-02 |
| Grade 1-vs-Grade 2 |
5.480200E-01 |
| Grade 1-vs-Grade 3 |
3.232000E-01 |
| Grade 1-vs-Grade 4 |
4.002800E-01 |
| Grade 2-vs-Grade 3 |
3.848900E-04 |
| Grade 2-vs-Grade 4 |
1.271860E-02 |
| Grade 3-vs-Grade 4 |
7.703800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.648400E-01 |
| Normal-vs-ccB subtype |
6.296100E-02 |
| ccA subtype-vs-ccB subtype |
4.737100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.680600E-01 |
| Normal-vs-N1 |
9.264000E-01 |
| N0-vs-N1 |
8.718800E-01 |
|
|
